2017 | Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
| RADIATION ONCOLOGY JOURNAL |
2013 | Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients | AMERICAN JOURNAL OF HEMATOLOGY |
2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
2015 | Hemophagocytic Lymphohistiocytosis after Lung Transplantation
| Korean Journal of Critical Care Medicine |
2006 | High dose chemotherapy and autologous stem cell transplantation in non-Hodgkin's lymphoma: An eight-year experience
| YONSEI MEDICAL JOURNAL |
2016 | High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. | LEUKEMIA & LYMPHOMA |
2014 | High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2020 | Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation
| PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
2022 | Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients
| JOURNAL OF MOLECULAR DIAGNOSTICS |
2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
2023 | In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources
| STEM CELL RESEARCH & THERAPY |
2014 | Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES |
2019 | Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
2003 | Induction of Apoptosis by Apicidin, a Histone Deacetylase Inhibitor, via the Activation of Mitochondria-Dependent Caspase Cascades in Human Bcr-Abl-Positive Leukemia Cells
| CLINICAL CANCER RESEARCH |
2015 | Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine | BIOMEDICINE & PHARMACOTHERAPY |
2013 | Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
| ANNALS OF ONCOLOGY |
2005 | Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2010 | Inhibition of CK2{alpha} and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells. | ANTICANCER RESEARCH |
2004 | Isolated Extramedullary Relapse of Acute Myelogenous Leukemia as a Uterine Granulocytic Sarcoma in an Allogeneic Hematopoietic Stem Cell Transplantation Recipient
| YONSEI MEDICAL JOURNAL |
2013 | Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients
| BLOOD RESEARCH |
2002 | Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia. | LEUKEMIA RESEARCH |
2007 | Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
| YONSEI MEDICAL JOURNAL |
2011 | Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy.
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
2014 | Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification | ANNALS OF HEMATOLOGY |
2014 | Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes | INTERNATIONAL JOURNAL OF HEMATOLOGY |
2010 | Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells
| JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS |
2012 | Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant
| YONSEI MEDICAL JOURNAL |
2009 | Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction | BRITISH JOURNAL OF HAEMATOLOGY |
2006 | Nine-year survival of lymphoblastic lymphoma patients
| YONSEI MEDICAL JOURNAL |
2001 | NK/T 세포 림프종 환자에서 시행된 비골수제거성 조혈모세포이식
| 대한조혈모세포이식학회지 |
2012 | Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients | MEDICAL ONCOLOGY |
2013 | Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
| RADIATION ONCOLOGY JOURNAL |
2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2022 | Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
2003 | Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome | BRITISH JOURNAL OF HAEMATOLOGY |
2018 | Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
| JOURNAL OF TRANSLATIONAL MEDICINE |
2024 | Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest
| CANCERS |
2015 | Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation
| BLOOD RESEARCH |
2022 | Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
| CANCER RESEARCH AND TREATMENT |
2016 | Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
2016 | Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2023 | Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis | JOURNAL OF NEPHROLOGY |
2016 | Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
| PLOS ONE |
2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | LEUKEMIA RESEARCH |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2007 | Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia
| CLINICAL CANCER RESEARCH |
2015 | Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
2022 | Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma | BRITISH JOURNAL OF HAEMATOLOGY |
2022 | Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
| CELL TRANSPLANTATION |
2016 | Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
| BMC CANCER |
2012 | Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2020 | RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
| SCIENTIFIC REPORTS |
2014 | Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients | INTERNATIONAL JOURNAL OF HEMATOLOGY |
2022 | Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
| BLOOD RESEARCH |
2017 | Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience | ANNALS OF HEMATOLOGY |
2016 | Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. | LEUKEMIA & LYMPHOMA |
2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
2014 | Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes
| PLOS ONE |
2015 | Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
| BLOOD CANCER JOURNAL |